List of insiders holdings for Surface Oncology Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Novartis Institutes for BioMedical Research Inc. NOVARTIS AG 10% Owner |
2021-02-08 17:24:15 | 3,948,482 0 |
3,948,482 | Form 13G |
2 | EcoR1 Capital LLC 10% Owner |
2023-02-13 14:08:49 | 3,924,713 0 |
3,924,713 | Form 13G |
3 | LV Management Group LLC Lilly Ventures Fund I LLC Torres S. Edward Hall Steven Edward 10% Owner |
2021-02-12 17:08:20 | 3,447,817 0 |
3,447,817 | Form 13G |
4 | BARRETT M JAMES 10% Owner |
2018-04-23 16:45:32 | 0 3,312,877 |
3,312,877 | Form 4 |
5 | BARRIS PETER J 10% Owner |
2018-04-23 16:45:54 | 0 3,312,877 |
3,312,877 | Form 4 |
6 | MOTT DAVID M 10% Owner |
2018-04-23 16:47:32 | 0 3,312,877 |
3,312,877 | Form 4 |
7 | Viswanathan Ravi 10% Owner |
2018-04-23 16:48:47 | 0 3,312,877 |
3,312,877 | Form 4 |
8 | Atlas Venture Fund IX L.P. Atlas Venture Associates IX L.P. Atlas Venture Associates IX LLC 10% Owner |
2023-01-31 08:57:04 | 2,945,453 0 |
2,945,453 | Form 13G |
9 | FMR LLC See Remark 1 |
2022-02-09 10:01:24 | 1,729,801 0 |
1,729,801 | Form 13G |
10 | FIL Ltd See Remark 1 |
2018-04-25 15:56:29 | 886,716 0 |
886,716 | Form 4 |
11 | October 2017 Liquidating Trust Kearney Michael J See Remark 1 |
2018-04-25 14:38:46 | 0 406,113 |
406,113 | Form 4 |
12 | Chappel Scott C Chief Technology Officer |
2018-04-18 17:00:16 | 372,029 0 |
372,029 | Form 3 |
13 | Boni Theresa General Counsel & Secretary |
2022-04-01 20:00:25 | 120,000 0 |
120,000 | Form 4 |
14 | Dwyer Wendy Chief Business Officer |
2020-03-03 16:05:11 | 85,000 0 |
85,000 | Form 4 |
15 | Nogelo Liisa I Chief Legal Officer |
2022-01-14 20:30:22 | 53,675 0 |
53,675 | Form 4 |
16 | Brunn Carsten Director |
2022-06-30 20:05:24 | 48,000 0 |
48,000 | Form 4 |
17 | Ibrahim Ramy Director |
2022-06-10 20:00:27 | 24,000 0 |
24,000 | Form 4 |
18 | Torres Denice Director |
2022-06-10 20:00:41 | 24,000 0 |
24,000 | Form 4 |
19 | Stelzer Laurie Director |
2022-06-10 20:00:37 | 24,000 0 |
24,000 | Form 4 |
20 | Hickey Benjamin Director |
2022-06-10 20:00:32 | 24,000 0 |
24,000 | Form 4 |
21 | Shanafelt Armen Director 10% Owner |
2022-06-10 20:00:46 | 24,000 0 |
24,000 | Form 4 |
22 | MCDONOUGH GEOFF Director |
2021-06-10 16:30:16 | 17,700 0 |
17,700 | Form 4 |
23 | LYNCH DANIEL Director |
2020-06-12 08:00:13 | 12,000 0 |
12,000 | Form 4 |
24 | Sigal Charles Elliott Director |
2023-09-08 16:00:37 | 0 0 |
0 | Form 4 |
25 | Adams Chandra Deputy GC |
2023-09-08 16:00:31 | 0 0 |
0 | Form 4 |
26 | RATH HENRY C. Chief Business Officer |
2023-09-08 16:00:30 | 0 0 |
0 | Form 4 |
27 | Goater Jeff Director |
2023-09-08 16:00:25 | 0 0 |
0 | Form 4 |
28 | Palombella Vito J. Chief Scientific Officer |
2023-09-08 16:00:25 | 0 0 |
0 | Form 4 |
29 | FEES JESSICA Chief Financial Officer |
2023-09-08 16:00:23 | 0 0 |
0 | Form 4 |
30 | ROSS ROBERT W. Chief Executive Officer |
2023-09-08 16:00:22 | 0 0 |
0 | Form 4 |
31 | GRAYZEL DAVID S. Director |
2023-09-08 16:00:17 | 0 0 |
0 | Form 4 |
32 | ONEILL ALISON Chief Medical Officer |
2023-09-08 16:00:14 | 0 0 |
0 | Form 4 |
33 | New Enterprise Associates 14 L.P. NEA Partners 14 L.P. NEA 14 GP LTD BASKETT FOREST Florence Anthony A. Jr. KERINS PATRICK J SANDELL SCOTT D Sonsini Peter W. 10% Owner |
2021-02-12 13:28:09 | 0 0 |
0 | Form 13G |